FY20 new start-JW200170: CNP8 delivered topically in a tyrosine
Active Definitive Contract Awarded Last action
- Contract number
- W81XWH22C0005
- Awardee
-
Neomatrix Therapeutics Inc. UEI Z9ZTKJPE92R4
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $2,923,902
Award facts
- Contract value 100% obligated
- $2,923,902.00 Current and potential, with all options
- Completion date 86% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Fixed Price Level of Effort
- Place of performance
- Stony Brook, NY 11790, USA
- Legislative mandates
-
- Walsh-Healey Public Contracts Act FAR subpart 22.6
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Change Order | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $2,923,902 |
About this award
The Defense Health Agency awarded a $2.92 million fixed-price level-of-effort definitive contract to Neomatrix Therapeutics Inc. on September 8, 2022, with no set-aside used. The prime is described in the source as a self-certified small disadvantaged business. The contract covers development of CNP8, a tyrosine-derived fiber mat delivered topically to reduce burn injury progression, speed wound closure, and mitigate scarring, under FY20 new start JW200170. Work is performed in Stony Brook, NY 11790, with an ultimate completion date of July 31, 2027. The $2.92 million figure is the ceiling value, and the source does not report an obligated amount separately.
Quick answers
Who was awarded contract W81XWH22C0005?
W81XWH22C0005 was awarded to Neomatrix Therapeutics Inc. by Defense Health Agency (Department of Defense) on September 8, 2022.
How much is contract W81XWH22C0005 worth?
The government has obligated $2,923,902 on W81XWH22C0005.
Was contract W81XWH22C0005 competed?
The extent of competition for W81XWH22C0005 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award